In Depth 21 Nov 2024
Huntington’s disease: a therapeutic field on a bumpy ride
For years, biotechs have been trying to develop medicines to cure the disease but much to no avail. Now, as clinical studies advance, there is hope.
Neurodegenerative disease
- Latest Posts
News and Trends 15 Oct 2024
Booster launches to treat neurodegenerative diseases with proteasome activation
Discover Booster Therapeutics’ novel proteasome activation approach to neurodegenerative diseases as it launches with $15 million.
In Depth 26 Sep 2024
The radiopharmaceutical revolution: From diagnosis to treatment, oncology and beyond
Delve into the world of radiopharmaceuticals: explore their mechanisms, promising candidates, and the key players driving innovation.
In Depth 19 Sep 2024
Mitochondrial disease treatments: is a breakthrough on the horizon?
Mitochondrial dysfunction is linked to many diseases. Discover how biotechs are developing mitochondrial disease treatments to address these diseases.
News and Trends 1 Aug 2024
European regulators reject Alzheimer’s drug Leqembi: is it downhill from here?
European regulators have now refused to market the Alzheimer’s drug Leqembi after it was approved by the FDA last year.
More News! 17 Jul 2024
Is tau protein the key to defeating Alzheimer’s? Asceneuron thinks so and raises $100 million to prove it
Discover yet another exciting deal in biotech with Asceneuron raising $100 million to advance its Alzheimer’s candidate, ASN51.
ADVERTISEMENT
ADVERTISEMENT
In Depth 4 Jul 2024
Parkinson’s disease: biotech’s pursuit for more therapies
Rigorous research aims to boost therapeutic options for people with Parkinson’s disease. What do biotechs have in store?
Best in Biotech 30 May 2024
Stem cell therapy’s avant-garde: Eight companies leading the way
Stem cell therapy has gained traction over the recent years and the market is growing, discover eight companies advancing the field.
Podcast 15 Mar 2024
Reformulating psychedelics for neurodegenerative diseases
Discover how Terran Biosciences is at the forefront of revolutionizing neurological care through innovative psychedelics treatments.
In Depth 19 Jan 2024
Re-coding the brain: Is CRISPR capable of curing neurodegenerative diseases?
Check out our latest article as we explore some of the latest research around using CRISPR technology to treat neurodegenerative diseases.
Podcast 12 Jan 2024
Could natural killer cells transform Alzheimer’s treatment?
Join Dr. Paul Song, CEO of NKGen Biotech, in a podcast exploring the revolutionary use of NK cells for Alzheimer’s treatment.
In Depth 9 Nov 2023
Blood tests for Alzheimer’s: a hit or a miss?
Doctor’s typically diagnose Alzheimer’s with the help of brain imaging and cognitive tests, along with taking a patient’s medical history into account. But lately, blood tests are gaining recognition for its ability to rule out other potential causes of memory loss, and to diagnose Alzheimer’s more quickly. With American healthcare company Labcorp launching its trio […]
ADVERTISEMENT
